New MRI lesions and topography at 6 months of treatment initiation and disease activity during follow up in relapsing remitting multiple sclerosis patients
- 20 January 2020
- journal article
- research article
- Published by Taylor & Francis in Neurological Research
- Vol. 42 (2) , 148-152
Abstract
Objective: The objective of this study was to assess if the presence of new lesions and their topography on the reference MRI have a prognostic value regarding disease activity during the follow up in relapsing remitting multiple sclerosis (RRMS) patients. Methods: Retrospective cohort study that included patients with RRMS who had a reference MRI (performed at 6 months from the onset of a DMT) and radiological and clinical follow up for at least two years. We identified the number of new MRI lesions and their topography at reference MRI and during the follow up. Cox proportional hazards model analysis was used to evaluate the association between new lesions on reference MRI and the appearance of new lesions and/or clinical relapses at 24-month follow-up. Results: 56 patients were included, 13 (23.2%) showed new lesions in the reference MRI. The presence of new lesions at reference MRI predicted the occurrence of new lesions at month 24 (HR 3.1, CI 95% 2.5-5.8). The number of lesions and the infratentorial topography at reference MRI were associated with an increased risk of new radiological activity during follow up (HR 3.5, IC95% 3.1-6.1 and HR 2.4, IC95% 1.9-2.7 respectively). Conclusion: New lesions at the reference MRI in terms of number and topography increase the risk of radiological disease activity during the follow up.Keywords
This publication has 24 references indexed in Scilit:
- Unraveling treatment response in multiple sclerosisNeurology, 2019
- Multiple sclerosisThe Lancet, 2018
- MR Imaging in Monitoring and Predicting Treatment Response in Multiple SclerosisNeuroimaging Clinics Of North America, 2017
- Assessing response to interferon-β in a multicenter dataset of patients with MSNeurology, 2016
- MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patientsNature Reviews Neurology, 2015
- MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic processNature Reviews Neurology, 2015
- Predicting responders to therapies for multiple sclerosisNature Reviews Neurology, 2009
- Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Multiple sclerosisThe Lancet, 2002
- Multiple SclerosisNew England Journal of Medicine, 2000